Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07518706
What this trial is testing

Neoadjuvant Tislelizumab-Lenvatinib vs Surgery Alone in Stage Ia HCC With Narrow Margin

Who this might be right for
HCC - Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00806663
What this trial is testing

FOLFIRI and Sunitinib in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerLiver Metastases
Central European Society for Anticancer Drug Research 22
Testing effectiveness (Phase 2)WithdrawnNCT03722498
What this trial is testing

Phase Ⅱ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Testing effectiveness (Phase 2)Active Not RecruitingNCT04175912
What this trial is testing

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the Liver

Who this might be right for
Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+12 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)WithdrawnNCT00039078
What this trial is testing

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Allan Tsung
Not applicableUnknownNCT05202015
What this trial is testing

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

Who this might be right for
HCCHepatocellular CarcinomaMRI
Charite University, Berlin, Germany 150
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Not applicableActive Not RecruitingNCT05128123
What this trial is testing

Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 1,600
Not applicableLooking for participantsNCT05994859
What this trial is testing

SIRT for Potentially Resectable HCC

Who this might be right for
Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 35
Early research (Phase 1)Study completedNCT03175679
What this trial is testing

Adoptive Transfer of iNKT Cells for Treating Patients With Relapsed/Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Beijing YouAn Hospital 10
Not applicableEnded earlyNCT02336763
What this trial is testing

Radiation Therapy in Preventing Liver Metastases in Patients With Uveal Melanoma Who HaveMonosomy 3 or DecisionDx Class 2 Disease and Are More Likely to Develop Liver Metastases

Who this might be right for
Iris MelanomaMedium/Large Size Posterior Uveal MelanomaStage IIA Uveal Melanoma+4 more
Jonsson Comprehensive Cancer Center 2
Testing effectiveness (Phase 2)Study completedNCT05007106
What this trial is testing

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

Who this might be right for
Uterine Cervical NeoplasmsEndometrial NeoplasmsSquamous Cell Carcinoma of Head and Neck+8 more
Merck Sharp & Dohme LLC 613
Testing effectiveness (Phase 2)Looking for participantsNCT07447050
What this trial is testing

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Who this might be right for
Breast CancerSarcomaGastric (Stomach) Cancer+7 more
University of California, Irvine 24
Not applicableStudy completedNCT06626724
What this trial is testing

A Retrospective Cohort Study on Predicting Delayed Graft Function in Liver Transplant Patients with Hepatocellular Carcinoma: a Nomogram and Machine Learning Approaches.

Who this might be right for
Hepatocellular Carcinoma (HCC)DGF
Jian You 131
Testing effectiveness (Phase 2)UnknownNCT05965817
What this trial is testing

Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN

Who this might be right for
Colorectal CancerLiver Metastasis Colon CancerImage
Leiden University Medical Center 10
Not applicableStudy completedNCT05989789
What this trial is testing

Radioactive Seed-guided Resection of Cholangiocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Liver CancerLiver Cirrhosis
Clarunis - Universitäres Bauchzentrum Basel 2
Not applicableStudy completedNCT05178524
What this trial is testing

Clinical Study on BIFICO Accelerating Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma

Who this might be right for
Gut MicrobiotaHepatocellular CarcinomaBifidobacterium
Tongji Hospital 180
Not applicableLooking for participantsNCT06573723
What this trial is testing

Institutional Registry of Rare Diseases

Who this might be right for
Rare DiseasesAmyloidosisSarcoidosis+23 more
Hospital Italiano de Buenos Aires 380
Not applicableUnknownNCT03295591
What this trial is testing

Circulating Tumor Cells in mCRC for Liver Resection

Who this might be right for
Metastatic Colorectal CancerCirculating Tumor Cell
The University of Hong Kong 77
Large-scale testing (Phase 3)Ended earlyNCT02460991
What this trial is testing

ONCO-DOX in Locally Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cell Carcinoma
Boston Scientific Corporation 2
Next Page